Vitamin K is an essential nutrient, with its K2 form gaining increasing attention for its potential roles beyond blood clotting. Specifically, vitamin K2 (menaquinone) is a family of compounds, the most commonly discussed forms being menaquinone-4 (MK-4) and menaquinone-7 (MK-7). For women in midlife and menopause, understanding these distinctions can be particularly relevant.
This article aims to provide an evidence-based overview of MK-4 and MK-7, examining their characteristics and how they might differ in their potential effects within the body. We will focus on existing research to help clarify which form might be more suitable for individual needs, emphasizing that this information is for educational purposes only and not medical advice.
What is Vitamin K2?
Vitamin K is a fat-soluble vitamin known for its role in blood coagulation. However, vitamin K2, specifically, is involved in activating proteins that help manage calcium in the body. These proteins include osteocalcin, which helps integrate calcium into bone, and matrix Gla protein (MGP), which helps regulate calcium in soft tissues like arteries.
Unlike vitamin K1, which is primarily found in green leafy vegetables, vitamin K2 is found in fermented foods and animal products. The two main forms of vitamin K2 that are often discussed in dietary supplements are menaquinone-4 (MK-4) and menaquinone-7 (MK-7).
Menaquinone-4 (MK-4): Characteristics and Sources
MK-4 is a short-chain menaquinone, meaning it has a shorter side chain compared to other K2 forms. It is found in animal-derived foods such as egg yolks, butter, and certain organ meats. In the body, some vitamin K1 can be converted into MK-4, though the efficiency of this conversion can vary.
Research has explored MK-4’s potential impact on bone health. While MK-4 has been studied for its effects, its bioavailability and half-life in the bloodstream are generally shorter compared to MK-7 [1]. This means it may not remain in circulation for as long after consumption.
Menaquinone-7 (MK-7): Characteristics and Sources
MK-7 is a long-chain menaquinone, characterized by a longer side chain. It is predominantly found in fermented foods, most notably natto, a traditional Japanese fermented soybean dish. Bacteria involved in fermentation processes can produce MK-7.
One significant difference between MK-4 and MK-7 lies in their bioavailability and half-life. Studies have indicated that MK-7 has a longer half-life in the blood compared to MK-4, suggesting it may accumulate to higher levels and remain in circulation for a longer duration after intake [1]. This extended presence in the bloodstream might allow for more sustained activation of vitamin K-dependent proteins. Research has also investigated MK-7’s effects on bone quality and strength [2] and its potential role in conditions like rheumatoid arthritis [3] and periodontitis [4].
MK-4 vs. MK-7: Bioavailability and Efficacy
The distinction in bioavailability is a key factor when considering MK-4 and MK-7. A study comparing the bioavailability of MK-4 and MK-7 in healthy women found that MK-7 demonstrated superior bioavailability, leading to higher and more sustained plasma concentrations compared to MK-4 [1]. This suggests that MK-7 may be more effective at reaching target tissues and maintaining its presence in the body over time.
The longer half-life of MK-7 could mean that it is more efficient at activating vitamin K-dependent proteins throughout the body, including those involved in bone mineralization and arterial health. For women in midlife and menopause, who may be focusing on supporting bone density, the sustained action of MK-7 might be a consideration. While both forms contribute to vitamin K activity, the pharmacokinetic differences between them are notable.
Which Form May Be Best for You?
When considering vitamin K2 supplementation, the choice between MK-4 and MK-7 often comes down to individual goals and existing research. Given the evidence on bioavailability, MK-7 is often considered for its potential to provide more consistent and prolonged vitamin K activity in the body [1]. This sustained presence may be beneficial for supporting long-term bone health and cardiovascular well-being, which are common considerations for women in midlife and menopause.
However, it’s important to recognize that both forms have specific characteristics. Some dietary supplements combine both MK-4 and MK-7, aiming to provide benefits from both shorter and longer-acting forms. Ultimately, the ‘best’ form can depend on individual dietary intake, specific health goals, and discussions with a healthcare provider. There is no one-size-fits-all answer, and personal circumstances should always be taken into account.
References
- Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutrition journal, 2012
- MK-7 and Its Effects on Bone Quality and Strength. Nutrients, 2020
- Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study. European journal of pharmacology, 2015
- A Case Control Study Evaluating the Relationship between Vitamin K2 Serum Level and Periodontitis. Healthcare (Basel, Switzerland), 2023
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.